Holdings (Monthly)
Guide ↗
iShares Neuroscience and Healthcare ETF
· iShares Trust| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Xenon Pharmaceuticals Inc | 98420N105 | Apr 2024 | 4,264 | -43 | $267K | +51.3% | 4.87% | EC |
| 2 | ALKERMES PUBLIC LIMITED COMPANY | G01767105 | Jan 2026 | 5,153 | -1,415 | $252K | +13.4% | 4.60% | EC |
| 3 | AXSOME THERAPEUTICS, INC. | 05464T104 | Jan 2026 | 949 | -350 | $207K | -13.6% | 3.77% | EC |
| 4 | Edgewise Therapeutics Inc | 28036F105 | Apr 2024 | 4,615 | -282 | $177K | +28.7% | 3.23% | EC |
| 5 | SUPERNUS PHARMACEUTICALS, INC. | 868459108 | Apr 2024 | 3,202 | -291 | $143K | -15.1% | 2.61% | EC |
| 6 | SAREPTA THERAPEUTICS, INC. | 803607100 | Apr 2024 | 5,954 | -382 | $88K | -31.3% | 1.61% | EC |
| 7 | Taysha Gene Therapies Inc | 877619106 | Jan 2026 | 13,999 | -327 | $82K | +27.0% | 1.50% | EC |
| 8 | Rapport Therapeutics Inc | 75383L102 | Jan 2026 | 1,673 | -131 | $69K | +42.8% | 1.25% | EC |
| 9 | INTEGRA LIFESCIENCES HOLDINGS CORPORATION | 457985208 | Apr 2024 | 3,915 | -312 | $65K | +38.4% | 1.19% | EC |
| 10 | Bright Minds Biosciences Inc | 10919W405 | Jan 2026 | 445 | -55 | $33K | -16.1% | 0.59% | EC |
| 11 | Regenxbio Inc | 75901B107 | Jan 2026 | 2,749 | -211 | $27K | -19.4% | 0.49% | EC |
| 12 | Oncolys Biopharma Inc | J61461109 | Jan 2026 | 1,600 | -200 | $26K | +29.7% | 0.48% | EC |
| 13 | NEUROGENE INC. | 64135M105 | Jan 2026 | 740 | -116 | $24K | +61.0% | 0.44% | EC |
| 14 | Benitec Biopharma Inc | 08205P209 | Jan 2026 | 1,981 | -115 | $23K | -9.1% | 0.42% | EC |
| 15 | Prothena Corporation PLC | G72800108 | Jan 2026 | 2,759 | -25 | $22K | -8.7% | 0.41% | EC |
| 16 | Neuropace Inc | 641288105 | Apr 2024 | 1,543 | -91 | $20K | -19.5% | 0.36% | EC |
| 17 | VANDA PHARMACEUTICALS INC. | 921659108 | Apr 2024 | 3,342 | -175 | $17K | -35.7% | 0.31% | EC |
| 18 | Anavex Life Sciences Corp | 032797300 | Apr 2024 | 5,343 | -441 | $15K | -46.0% | 0.27% | EC |
| 19 | PEIJIA MEDICAL LIMITED | G6981F109 | Jan 2026 | 28,000 | -1,000 | $14K | -41.7% | 0.26% | EC |
| 20 | Larimar Therapeutics Inc | 517125100 | Apr 2024 | 3,008 | -315 | $11K | -2.3% | 0.21% | EC |
| 21 | Entrada Therapeutics Inc | 29384C108 | Apr 2024 | 1,328 | -62 | $9K | -43.3% | 0.16% | EC |
| 22 | Cognition Therapeutics Inc | 19243B102 | Jan 2026 | 4,543 | -842 | $4K | -31.1% | 0.07% | EC |